Summary
BIOTECHNOLOGY group BTG (down 23/4p at 1521/4p) said the costs of absorbing drugs developer Protherics were behind an annual loss of Pounds 11.3m. A year earlier it posted a profit of Pounds 10.7m. Revenues rose 13pc to Pounds 84.8m.
INTEREST ratesSee the full content of this document
Extract
Uk at a Glance [Eire Region]
European Cent...
See the full content of this document
Sponsored links
